Back to Search
Start Over
Bexarotene and systemic disease progression in CTCL?
- Source :
-
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2006 Aug; Vol. 55 (2), pp. 365-6; author reply 366. - Publication Year :
- 2006
- Subjects :
- Antineoplastic Agents therapeutic use
Bexarotene
Disease Progression
Humans
Mycosis Fungoides drug therapy
Reproducibility of Results
Risk Factors
Sezary Syndrome drug therapy
Tetrahydronaphthalenes therapeutic use
Antineoplastic Agents adverse effects
Lymphoma, T-Cell, Cutaneous drug therapy
Tetrahydronaphthalenes adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6787
- Volume :
- 55
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of the American Academy of Dermatology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 16844539
- Full Text :
- https://doi.org/10.1016/j.jaad.2006.01.022